News

Identifying the type of depression present in an individual with or at-risk for symptomatic knee osteoarthritis can help clinicians best target therapies to reduce pain and disability over time, according to a new study.

Adding acupuncture to topical ibuprofen can provide greater pain relief for patients with osteoarthritis who have chronic knee pain than treating them with only topical ibuprofen, according to recent research.

OARSI 2019: Today―in the era of shared decision making and patient-centered care―patient preferences should be incorporated into clinical practice.

OARSI 2019:  Readmission rates for joint surgery patients are down in Ontario where post-surgery in hospital stays have been shortened.

OARSI 2019:  Osteoarthritis of the hands may be more widespread than previously thought.

OARSI 2019: Phase IIIb clinical trial for the extended release injectable triamcinolone acetonide (Zilretta, Flexion) shows improvement in pain, stiffness and function. 

OARSI 2019:  Using a cane may not foster the growth of medial tibiofemoral bone marrow lesions (BML) in knee osteoarthritis.

OARSI 2019:  Men and women with a mother or sibling who have osteoarthritis, have an increased risk of osteoarthritis in the hips, knees and hands.

OARSI 2019:  Half of opioid prescriptions made today are not aligned with treatment guidelines.

French researchers writing in Arthritis and Rheumatology describe a biomarker that may determine the risk of mortality in patients with dermatomyositis who develop cancer, a common outcome in adults.

Patients with giant cell arteritis treated weekly or bi-weekly with tocilizumab and a prednisone taper experience better outcomes than those treated only with prednisone, a new study shows.

The TNF-inhibitor biosimilar was shown to fare similarly to the marketed therapy in a 52-week efficacy trial.

A new study indicates that a high bone mineral density test of the femoral neck may serve as an indicator of knee and hip osteoarthritis onset.

The expanded indication allows the use of intravenous belimumab (Benlysta) in children as young as 5 years of age.

Patient access to biologic therapies is an issue throughout the European Union where the authors of a review article zero in on “why.” Access issues, they find, have a lot in common with access issues here in the U.S.

Rheumatoid arthritis, psoriasis and psoriatic arthritis patients have consistently low levels of biologic adherence and persistence. How can patient compliance be improved? Lower out-of-pocket costs, utilize specialty pharmacies and improve patient education.

Osteoarthritis patients over age 50 could face a greater risk of mortality after receiving an initial tramadol prescription compared to various commonly prescribed NSAIDS, according to new research.

Rheumatoid arthritis patients and rheumatology providers share many of the same concerns over obstacles that make it harder to reach treat-to-target goals, according to a new study.

Risankizumab (Skyrizi) is now approved for treating moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

The COAST-X trial evaluated the safety and efficacy of ixekizumab for the treatment of non-radiographic axial spondyloarthritis (nr-axSpA).

A trial of 172 patients with knee pain from osteoarthritis, shows that the active component of chili peppers called capsaicin, successfully and significantly reduced pain intensity. 

Axial spondyloarthritis (axSpA) is never a straightforward diagnosis. In this slideshow, we highlight 11 disease manifestations associated with axSpA.

Robert Terkeltaub M.D., the rheumatology section chief of the VA Medical Center in San Diego and the corresponding author of the first-ever treatment guidelines for gout by the American College of Rheumatology, recently spoke with Rheumatology Network about updates in gout treatment.

The study also found that the overall rate of cardiovascular events was low in the study population, indicating that statins aren’t required for all RA patients.

Mortality rates for white, African American and Hispanic patients with end stage lupus-related renal disease are down. The findings contradict a previous analysis conducted in 2006.

Patients with systemic lupus erythematosus often have a range of clinical symptoms that are nonspecific and overlap with other medical conditions, such as Sjögren’s syndrome, rheumatoid arthritis and Raynaud's syndrome.

Delays in diagnosing axSpA are troubling, write the authors of a report in the journal Rheumatology. Delays of up to 10 years have been reported. Not all physicians may be familiar with the signs and symptoms of axSpA.

Physiotherapy, exercise and pain medications should be part of the treatment plan to improve the quality of life of patients suffering from stiffness associated with axial spondyloarthritis.

Osteoarthritis and rheumatoid arthritis patients report having similar pain levels in the beginning, but by six months, osteoarthritis patients say their pain is worse. This suggests a need for more effective osteoarthritis treatments, say researchers writing in Arthritis & Rheumatology. In this Q&A, the study’s lead author, Theodore Pincus, M.D., of Rush University Medical Center in Chicago, shares his findings with us.

A new systematic review and meta-analysis shows that while NSAIDs peaks at two weeks, while gastrointestinal and cardiovascular adverse events linger.